The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has had a great start to the week and finds itself up 0.6% to 5,898 points in afternoon trade.
Four shares which have climbed more than most today are listed below. Here's why:
The Auscann Group Holdings Ltd (ASX: AC8) share price has jumped 6.5% to 82.5 cents after the pot stock announced its first medicinal cannabis crop in Chile is being harvested. Up to 300kgs of dried cannabis product will be processed into medicinal cannabis formulations. AusCann's share price has now rallied by over 300% since its IPO.
The Amaysim Australia Ltd (ASX: AYS) share price has jumped 4% to $1.91 following its $120 million acquisition of online energy retailer Click Energy Group. Management expects the transaction to complete by June 2017 and be significantly accretive to earnings in FY 2018. Although it comes as a bit of a surprise, I'm willing to give its talented management team the benefit of the doubt on this one.
The BT Investment Management Ltd (ASX: BTT) share price is up 6% to $10.76 after the fund manager released its latest funds under management update. Thanks to large in-flows from its JO Hambro business, BTIM saw a 4.8% increase in funds under management despite significant foreign exchange headwinds.
The Mesoblast limited (ASX: MSB) share price has surged higher by 6.5% to $2.59 after the regenerative medicine company announced that it had completed its phase three heart failure trial. Today's gain means Mesoblast's shares have risen an astonishing 79% year-to-date.
